in a double-blind , randomised , placebo-controlled trial of intravenous acyclovir ( acv ) in normal adults with chickenpox , the drug was shown to have a significant effect on the duration of vesicles , on virus counts after one day 's treatment and in lowering the body temperature on the third , fourth and sixth days of treatment .
C0001367
acyclovir
C0008049
chickenpox